RANDEE KIDDER: Open Payments
NPI 1962820134 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,797 in 186 payments from 12 companies in 2025. Trend: 2023 $4,677 · 2024 $15,062 · 2025 $3,797
Food & beverage: $3,797
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 63 | $1,161 |
| Janssen Biotech, Inc. | 32 | $734 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $593 |
| Madrigal Pharmaceuticals | 13 | $505 |
| Lilly USA, LLC | 14 | $250 |
| Celltrion USA Inc. | 10 | $200 |
| PFIZER INC. | 7 | $149 |
| Daiichi Sankyo Inc. | 3 | $75 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Organon LLC | 3 | $42 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, RINVOQ, OMVOH, SKYRIZI, VEGZELMA, XELJANZ.
Industry payments across LA — which companies pay providers there.
